Chemed EBITDA Margin 2010-2024 | CHE
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Chemed (CHE) over the last 10 years. The current EBITDA margin for Chemed as of September 30, 2024 is .
| Chemed EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-06-30 |
$2.34B |
$0.42B |
18.02% |
| 2024-03-31 |
$2.29B |
$0.40B |
17.52% |
| 2023-12-31 |
$2.27B |
$0.40B |
17.75% |
| 2023-09-30 |
$2.23B |
$0.37B |
16.67% |
| 2023-06-30 |
$2.19B |
$0.37B |
16.69% |
| 2023-03-31 |
$2.16B |
$0.39B |
17.88% |
| 2022-12-31 |
$2.14B |
$0.40B |
18.88% |
| 2022-09-30 |
$2.13B |
$0.42B |
19.68% |
| 2022-06-30 |
$2.14B |
$0.43B |
20.07% |
| 2022-03-31 |
$2.14B |
$0.41B |
19.18% |
| 2021-12-31 |
$2.14B |
$0.40B |
18.79% |
| 2021-09-30 |
$2.13B |
$0.45B |
21.02% |
| 2021-06-30 |
$2.12B |
$0.43B |
20.28% |
| 2021-03-31 |
$2.09B |
$0.45B |
21.48% |
| 2020-12-31 |
$2.08B |
$0.45B |
21.50% |
| 2020-09-30 |
$2.07B |
$0.38B |
18.42% |
| 2020-06-30 |
$2.02B |
$0.37B |
18.21% |
| 2020-03-31 |
$1.99B |
$0.34B |
16.91% |
| 2019-12-31 |
$1.94B |
$0.30B |
15.68% |
| 2019-09-30 |
$1.88B |
$0.29B |
15.47% |
| 2019-06-30 |
$1.84B |
$0.29B |
15.51% |
| 2019-03-31 |
$1.81B |
$0.28B |
15.34% |
| 2018-12-31 |
$1.78B |
$0.28B |
15.87% |
| 2018-09-30 |
$1.75B |
$0.27B |
15.46% |
| 2018-06-30 |
$1.73B |
$0.26B |
15.24% |
| 2018-03-31 |
$1.70B |
$0.17B |
9.71% |
| 2017-12-31 |
$1.67B |
$0.15B |
9.00% |
| 2017-09-30 |
$1.64B |
$0.15B |
8.90% |
| 2017-06-30 |
$1.62B |
$0.14B |
8.35% |
| 2017-03-31 |
$1.59B |
$0.21B |
13.38% |
| 2016-12-31 |
$1.58B |
$0.22B |
13.71% |
| 2016-09-30 |
$1.57B |
$0.21B |
13.55% |
| 2016-06-30 |
$1.57B |
$0.22B |
14.06% |
| 2016-03-31 |
$1.56B |
$0.23B |
14.45% |
| 2015-12-31 |
$1.54B |
$0.22B |
14.25% |
| 2015-09-30 |
$1.52B |
$0.22B |
14.44% |
| 2015-06-30 |
$1.50B |
$0.21B |
14.04% |
| 2015-03-31 |
$1.47B |
$0.21B |
14.11% |
| 2014-12-31 |
$1.46B |
$0.21B |
14.16% |
| 2014-09-30 |
$1.43B |
$0.20B |
13.82% |
| 2014-06-30 |
$1.41B |
$0.19B |
13.35% |
| 2014-03-31 |
$1.41B |
$0.17B |
12.31% |
| 2013-12-31 |
$1.41B |
$0.18B |
12.45% |
| 2013-09-30 |
$1.43B |
$0.18B |
12.69% |
| 2013-06-30 |
$1.45B |
$0.19B |
13.06% |
| 2013-03-31 |
$1.44B |
$0.20B |
13.99% |
| 2012-12-31 |
$1.43B |
$0.20B |
13.71% |
| 2012-09-30 |
$1.41B |
$0.20B |
13.89% |
| 2012-06-30 |
$1.40B |
$0.20B |
14.31% |
| 2012-03-31 |
$1.38B |
$0.20B |
14.23% |
| 2011-12-31 |
$1.36B |
$0.19B |
14.17% |
| 2011-09-30 |
$1.34B |
$0.18B |
13.72% |
| 2011-06-30 |
$1.32B |
$0.18B |
13.56% |
| 2011-03-31 |
$1.30B |
$0.18B |
13.59% |
| 2010-12-31 |
$1.28B |
$0.18B |
14.06% |
| 2010-09-30 |
$1.25B |
$0.17B |
13.79% |
| 2010-06-30 |
$1.22B |
$0.17B |
13.64% |
| 2010-03-31 |
$1.20B |
$0.16B |
13.37% |
| 2009-12-31 |
$1.19B |
$0.16B |
13.53% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$8.277B |
$2.264B |
|
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
|
